At a Glance
| 2C-T-7 | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 15–25 mg | 100–225 µg |
| Total Duration | 4.2–7 hrs | 3.3–7 hrs |
| Routes | insufflatedoral | oral |
2C-T-7, a Psychedelic, and 1cP-AL-LAD, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 46 documented effects in common, with 13 effects unique to 2C-T-7 and 26 unique to 1cP-AL-LAD. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2C-T-7 | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 15–25 mg | 100–225 µg |
| Total Duration | 4.2–7 hrs | 3.3–7 hrs |
| Routes | insufflatedoral | oral |
| Effects | 59 documented | 72 documented |
| Interaction | Low Risk & Synergy | |
| Level | 2C-T-7 | 1cP-AL-LAD |
|---|---|---|
| Threshold | 3 mg | 20 µg |
| Light | 10–15 mg | 50–100 µg |
| Common | 15–25 mg | 100–225 µg |
| Strong | 25–40 mg | 225–350 µg |
| Heavy | 40 mg | 350 µg |
| Level | Dose |
|---|---|
| Threshold | 1 mg |
| Light | 2–5 mg |
| Common | 5–10 mg |
| Strong | 10–15 mg |
2C-T-7
1cP-AL-LAD
Cross-tolerance exists; effects compound
No dangerous interactions recorded.
No dangerous interactions recorded.